---
title: "FORWARD Act of 2022"
identifier: "117-S-3498"
congress: 117
bill_number: 3498
bill_type: "S"
version_code: "is"
version_type: "Introduced in Senate"
bill_url: "https://chamberzero.com/congresses/117/bills/s/3498"
source: "https://www.congress.gov/bill/117th-congress/senate-bill/3498"
site: "Chamber Zero"
site_url: "https://chamberzero.com"
rendered_at: "2026-06-03T23:39:46.038Z"
---
# Full Text Index

Full inline text is not available for this bill version in the current text index, but the section-level markdown is available below.

- [SECTION 1 Short title](/congresses/117/bills/s/3498/sections/1-section-one.md)
- [SECTION 2 Continuing support for research on endemic fungal diseases](/congresses/117/bills/s/3498/sections/2.md)
- [SECTION 3 Endemic fungal disease working group](/congresses/117/bills/s/3498/sections/3.md)
- [SECTION 4 FDA guidance for industry on development of diagnostics and antifungal drugs and vaccines for Valley Fever](/congresses/117/bills/s/3498/sections/4.md)
- [SECTION 5 Priority review; fast track product](/congresses/117/bills/s/3498/sections/5.md)
- [SECTION 6 Priority review vouchers for products for prevention or treatment of endemic fungal diseases](/congresses/117/bills/s/3498/sections/6.md)
- [SECTION 7 Combating antimicrobial resistance biopharmaceutical accelerator program](/congresses/117/bills/s/3498/sections/7.md)